Gold HK - Search Results

1

Synergistic antithrombotic properties of G4120, a RGD-containing synthetic peptide, and argatroban, a synthetic thrombin inhibitor, in a hamster femoral vein platelet-rich thrombosis model.

Imura Y, Stassen JM, Vreys I, Lesaffre E, Gold HK, Collen D. Imura Y, et al. Among authors: gold hk. Thromb Haemost. 1992 Sep 7;68(3):336-40. Thromb Haemost. 1992. PMID: 1440501

2

Absence of potentiation with murine antiplatelet GPIIb/IIIa antibody of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in a canine venous thrombosis model.

Spriggs D, Gold HK, Hashimoto Y, Van Houtte E, Vermylen J, Collen D. Spriggs D, et al. Among authors: gold hk. Thromb Haemost. 1989 Feb 28;61(1):93-6. Thromb Haemost. 1989. PMID: 2501892

3

Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.

Collen D, Stassen JM, Yasuda T, Refino C, Paoni N, Keyt B, Roskams T, Guerrero JL, Lijnen HR, Gold HK, et al. Collen D, et al. Among authors: gold hk. Thromb Haemost. 1994 Jul;72(1):98-104. Thromb Haemost. 1994. PMID: 7974384

4

Contribution of platelets and the vessel wall to the antithrombotic effects of a single bolus injection of Fab fragments of the antiplatelet GPIIb/IIIa antibody 7E3 in a canine arterial eversion graft preparation.

Kiss RG, Stassen JM, Deckmyn H, Roskams T, Gold HK, Plow EF, Collen D. Kiss RG, et al. Among authors: gold hk. Arterioscler Thromb. 1994 Mar;14(3):375-80. doi: 10.1161/01.atv.14.3.375. Arterioscler Thromb. 1994. PMID: 8123641

5

Antithrombotic effects and bleeding time prolongation with synthetic platelet GPIIb/IIIa inhibitors in animal models of platelet-mediated thrombosis.

Collen D, Lu HR, Stassen JM, Vreys I, Yasuda T, Bunting S, Gold HK. Collen D, et al. Among authors: gold hk. Thromb Haemost. 1994 Jan;71(1):95-102. Thromb Haemost. 1994. PMID: 8165652

6

G4120, an Arg-Gly-Asp containing pentapeptide, enhances arterial eversion graft recanalization with recombinant tissue-type plasminogen activator in dogs.

Lu HR, Gold HK, Wu Z, Yasuda T, Pauwels P, Rapold HJ, Napier M, Bunting S, Collen D. Lu HR, et al. Among authors: gold hk. Thromb Haemost. 1992 Jun 1;67(6):686-91. Thromb Haemost. 1992. PMID: 1509410

7

New developments in thrombolytic therapy.

Collen D, Gold HK. Collen D, et al. Among authors: gold hk. Adv Exp Med Biol. 1990;281:333-54. Adv Exp Med Biol. 1990. PMID: 2129372 Review.

8

New developments in thrombolytic therapy.

Collen DC, Gold HK. Collen DC, et al. Among authors: gold hk. Thromb Res Suppl. 1990;10:105-31. doi: 10.1016/0049-3848(90)90384-o. Thromb Res Suppl. 1990. PMID: 2180114 Review.

9

Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition.

Jang IK, Gold HK, Ziskind AA, Leinbach RC, Fallon JT, Collen D. Jang IK, et al. Among authors: gold hk. Circulation. 1990 Jan;81(1):219-25. doi: 10.1161/01.cir.81.1.219. Circulation. 1990. PMID: 2297828

10

Thrombolytic therapy.

Collen D, Stump DC, Gold HK. Collen D, et al. Among authors: gold hk. Annu Rev Med. 1988;39:405-23. doi: 10.1146/annurev.me.39.020188.002201. Annu Rev Med. 1988. PMID: 3130773 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters